THYROCARE

Thyrocare Technologies Cash Flow

₹516.55-2.50%
Market cap
₹8,222 crore
P/E
46.6
P/B
14.04
ROE
28.8%
Dividend yield
1.36%

In the year ended Mar 2022, Thyrocare Technologies generated ₹1,400 crore from operating activities, invested ₹600 crore and paid out ₹550 crore on financing activities. Net cash flow for the year was ₹250 crore. Free cash flow was ₹950 crore.

Thyrocare Technologies cash flow statement

Financial years, newest first. Negative figures are cash outflows.

Thyrocare Technologies cash flows (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activities1,400129168180213
Cash from investing activities-600-39-91-41-23
Cash from financing activities-550-86-85-130-170
Net cash flow2504-8821
Capital expenditure—————
Free cash flow95086106146192

Source: Company filings, in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Thyrocare Technologies cash flow — frequently asked questions

What is Thyrocare Technologies' operating cash flow?

Thyrocare Technologies' cash flow from operating activities was ₹1,400 crore in the year ended Mar 2022, rose 985.27% from ₹129 crore in Mar 2023.

What is Thyrocare Technologies' free cash flow?

Thyrocare Technologies' free cash flow — operating cash flow minus capital expenditure — was ₹950 crore in Mar 2022.

How much did Thyrocare Technologies spend on investing activities?

Net cash used in investing activities was ₹600 crore in Mar 2022. This covers capital expenditure, acquisitions and the purchase or sale of investments.

Same Data For Peers

Trade Thyrocare Technologies With ATS

Track THYROCARE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.